171 related articles for article (PubMed ID: 33312060)
41. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
Zhao Y; Jia Y; Li C; Shao R; Fang Y
Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
[TBL] [Abstract][Full Text] [Related]
42. Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment.
Xia J; Huang R; Chen Y; Liu Y; Wang J; Yan X; Zhang Z; Wu C
Aliment Pharmacol Ther; 2020 Jun; 51(11):1180-1187. PubMed ID: 32363582
[TBL] [Abstract][Full Text] [Related]
43. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
44. [Levels and Clinical Significances of sPD-1 and sPD-L1 in Peripheral Blood of Lymphoma Patients].
Liu XL; He P; Lei J; Zou LX; Peng L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1733-1738. PubMed ID: 38071053
[TBL] [Abstract][Full Text] [Related]
45. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
[No Abstract] [Full Text] [Related]
46. The role of soluble programmed death protein-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1) in rat corneal transplantation rejection.
Yi G; Yi R; Chen X; Peng L; Huang G; Fu M; Lu XH; Li H
Adv Clin Exp Med; 2021 Jan; 30(1):93-100. PubMed ID: 33438375
[TBL] [Abstract][Full Text] [Related]
47. High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma.
Lu T; Chen Y; Li J; Guo Q; Lin W; Zheng Y; Su Y; Zong J; Lin S; Ye Y; Pan J
Onco Targets Ther; 2020; 13():1757-1765. PubMed ID: 32161471
[TBL] [Abstract][Full Text] [Related]
48. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
49. Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy.
Zhao J; Zhang P; Wang J; Xi Q; Zhao X; Ji M; Hu G
Medicine (Baltimore); 2017 Feb; 96(7):e6102. PubMed ID: 28207525
[TBL] [Abstract][Full Text] [Related]
50. Serum soluble PD-1 plays a role in predicting infection complications in patients with acute pancreatitis.
Yu X; Pan Y; Fei Q; Lin X; Chen Z; Huang H
Immun Inflamm Dis; 2021 Mar; 9(1):310-318. PubMed ID: 33417300
[TBL] [Abstract][Full Text] [Related]
51. Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study.
Wu X; Xu L; Cheng Q; Nie L; Zhang S; Du Y; Xue J
Respir Med; 2020 May; 166():105948. PubMed ID: 32250876
[TBL] [Abstract][Full Text] [Related]
52. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
53. Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Larrinaga G; Solano-Iturri JD; Errarte P; Unda M; Loizaga-Iriarte A; Pérez-Fernández A; Echevarría E; Asumendi A; Manini C; Angulo JC; López JI
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562338
[TBL] [Abstract][Full Text] [Related]
54. Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
Okuma Y; Wakui H; Utsumi H; Sagawa Y; Hosomi Y; Kuwano K; Homma S
Clin Lung Cancer; 2018 Sep; 19(5):410-417.e1. PubMed ID: 29859759
[TBL] [Abstract][Full Text] [Related]
55. Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer.
Buderath P; Schwich E; Jensen C; Horn PA; Kimmig R; Kasimir-Bauer S; Rebmann V
Front Oncol; 2019; 9():1015. PubMed ID: 31681568
[No Abstract] [Full Text] [Related]
56. Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer.
Jovanović D; Roksandić-Milenković M; Kotur-Stevuljević J; Ćeriman V; Vukanić I; Samardžić N; Popević S; Ilić B; Gajić M; Simon M; Simon I; Spasojević-Kalimanovska V; Belić M; Mirkov D; Šumarac Z; Milenković V
J Med Biochem; 2019 Jul; 38(3):332-341. PubMed ID: 31156344
[TBL] [Abstract][Full Text] [Related]
57. Analysis of soluble programmed death-1 ligand-1 of lung cancer patients with different characteristics.
Zhu HB; Song X
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8690-8696. PubMed ID: 37782182
[TBL] [Abstract][Full Text] [Related]
58. Soluble Programmed Death-Ligand 1 (sPD-L1) as a Promising Marker for Head and Neck Squamous Cell Carcinoma: Correlations With Clinical and Demographic Characteristics.
Alrehaili AA; Gharib AF; Almalki A; Alghamdi A; Hawsawi NM; Bakhuraysah MM; Alhuthali HM; Etewa RL; Elsawy WH
Cureus; 2023 Aug; 15(8):e44338. PubMed ID: 37779773
[TBL] [Abstract][Full Text] [Related]
59. The predictive role of soluble programmed death ligand 1 in digestive system cancers.
Ruan J; Zhao Z; Qian Y; Xu R; Liao G; Kong FS
Front Oncol; 2023; 13():1170220. PubMed ID: 37519785
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis.
Li X; Zheng Y; Yue F
Target Oncol; 2021 Jan; 16(1):13-26. PubMed ID: 33222017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
